Furthermore, treatment with a recombinant ApoA1Milano was found to induce plaque regression in a rabbit model of atherosclerosis [38] while in vitro experiments using this recombinant protein also demonstrated increased CEC and enhanced antioxidant and anti-inflammatory functions compared with normal ApoA1 [39]. The gene discussed is APOA1; the disease is atherosclerosis.